10.750USD+10.750After-hours (ET)
Key Figures
10.050Open
10.500High
26.90KVolume
--P/E TTM
0.00P/E Dynamic
--Dividend TTM
--Turnover Ratio
10.750Prev. Close
9.720Low
227.27KTurnover
--P/E Static
--P/B
0.00%Div Yield TTM
--ROA
21.34052wk High
1.96Volume Ratio
--Net Profit
--Shares
--EPS TTM
-0.02Beta
--ROE
9.53552wk Low
7.25%Amplitude
--Gross Margin
0.00Market Cap
-8.26Reward/Risk
2.66%Risk Rate
Pharming Group NV News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Indicators
Pharming Group NV Info
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.
Ticker SymbolPHAR
CompanyPharming Group NV
CEOChouraqui (Fabrice)
Websitehttps://www.pharming.com/
Shareholders
FAQs
What is the current price of Pharming Group NV (PHAR)?
The current price of Pharming Group NV (PHAR) is 10.75.
What is the symbol of Pharming Group NV?
The ticker symbol of Pharming Group NV is PHAR.
What is the 52-week high of Pharming Group NV?
The 52-week high of Pharming Group NV is 21.34.
What is the 52-week low of Pharming Group NV?
The 52-week low of Pharming Group NV is 9.54.
Is Pharming Group NV (PHAR) currently rated as Buy, Hold, or Sell?
According to analysts, Pharming Group NV (PHAR) has an overall rating of STRONG BUY, with a price target of 2.21.
